BDBM50140791 1-(3-Bromo-4-cyano-2-hydroxy-phenyl)-3-(2-bromo-phenyl)-urea::CHEMBL28009
SMILES: Oc1c(NC(=O)Nc2ccccc2Br)ccc(C#N)c1Br
InChI Key: InChIKey=JZBNYZCKVBXHSV-UHFFFAOYSA-N
Data: 4 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-X-C chemokine receptor type 1 (Homo sapiens (Human)) | BDBM50140791 (1-(3-Bromo-4-cyano-2-hydroxy-phenyl)-3-(2-bromo-ph...) | PDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 2.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Inhibition of binding of IL-8 to membranes of cloned CXC chemokine receptor 1 expressed in CHO Cells using [125I]-IL-8 radioligand | J Med Chem 47: 1319-21 (2004) Article DOI: 10.1021/jm034248l BindingDB Entry DOI: 10.7270/Q29G5M7Q | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 2 (Homo sapiens (Human)) | BDBM50140791 (1-(3-Bromo-4-cyano-2-hydroxy-phenyl)-3-(2-bromo-ph...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Hangzhou Institute of Innovative Medicine Curated by ChEMBL | Assay Description Displacement of [125I]IL-8 from CXCR2 (unknown origin) stably expressed in CHO cells | Eur J Med Chem 185: (2020) Article DOI: 10.1016/j.ejmech.2019.111853 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 1 (Homo sapiens (Human)) | BDBM50140791 (1-(3-Bromo-4-cyano-2-hydroxy-phenyl)-3-(2-bromo-ph...) | PDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 2.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Hangzhou Institute of Innovative Medicine Curated by ChEMBL | Assay Description Displacement of [125I]IL-8 from CXCR1 (unknown origin) stably expressed in CHO cells | Eur J Med Chem 185: (2020) Article DOI: 10.1016/j.ejmech.2019.111853 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 2 (Homo sapiens (Human)) | BDBM50140791 (1-(3-Bromo-4-cyano-2-hydroxy-phenyl)-3-(2-bromo-ph...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Inhibition of binding of IL-8 to membranes of cloned CXC chemokine receptor 2 expressed in CHO Cells using [125I]-IL-8 radioligand | J Med Chem 47: 1319-21 (2004) Article DOI: 10.1021/jm034248l BindingDB Entry DOI: 10.7270/Q29G5M7Q | |||||||||||
More data for this Ligand-Target Pair |